SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2008-09-30
Filing Date Changed: 2008-11-06
Documents: 5
SEC Accession No.
0001193125-08-228158
Filing date: 2008-11-06
Accepted: 2008-11-06 17:27:28

Table of submitted documents:

Seq Type Document Size Description
1 10-Q d10q.htm 1837670 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008
2 EX-31.1 dex311.htm 12017 CERTIFICATION OF CHIEF EXECUTIVE OFFICER (302)
3 EX-31.2 dex312.htm 12026 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302)
4 EX-32.1 dex321.htm 3257 CERTIFICATION OF CHIEF EXECUTIVE OFFICER (906)
5 EX-32.2 dex322.htm 3193 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (906)
0001193125-08-228158.txt 1870229 Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 081168172
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

  Assistant Director 1
Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674
Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-126922 | Film No.: 081168173
SIC: 8060 Services-Hospitals

  Assistant Director 1
Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766
Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060